Another ADC biotech reels in big bucks as Mark Alles’ TORL nabs $158M
10 Apr 2024 //
ENDPTS
BMS accused of anticompetitive tactics to keep Pomalyst chugging
07 Sep 2023 //
FIERCE PHARMA
NICE recommends combination treatment for patients with multiple myeloma
24 Dec 2021 //
PHARMAFILE
Supreme Court won`t hear bid to challenge thalidomide settlement
10 Jun 2021 //
CTVNEWS
Accord Healthcare launches thalidomide for multiple myeloma treatment
23 Mar 2021 //
PHARMAFILE
E.C Approves Darzalex, Bortezomib, Thalidomide and Dexamethasone combo
20 Jan 2020 //
BUSINESS WIRE
Celgene backs out of $55M class-action settlement on claims
10 Jan 2020 //
FIERCE PHARMA
J&J darzalex-FDA approval in frontline multiple myeloma use as Sanofi rival
28 Sep 2019 //
ENDPTS
Takeda suffers another setback in its quest to expand myeloma drug’s reach
06 Jun 2019 //
ENDPTS
The shrinking biotech bazaar
05 Feb 2019 //
NATURE BIOTECH
Immunotherapy Combinations in Multiple Myeloma — Known Unknowns
07 Nov 2018 //
NEW ENGLAND JOURNAL OF MEDICINE
Thalomid (thalidomide) : Celgene Corp. v. West-Ward Pharmaceutical International
03 Sep 2018 //
PATENT LITIGATION
New nuance in thalidomide’s mechanism revealed
09 Aug 2018 //
CEN
FDA tries to shame drugmakers over tactics that delay generics
18 May 2018 //
FIERCE PHARMA
How A Drugmaker Gamed The System To Keep Generic Competition Away
17 May 2018 //
NPR
Celgene Pays $280m in False Claims Act Case in Which U.S. Did Not Intervene
02 Aug 2017 //
FDALAWBLOG
Celgene to pay $280 million to settle off-label marketing case
26 Jul 2017 //
REUTERS
EU Lawmakers Urge Germany to Broaden Access to Fund for Thalidomide Victims
16 Dec 2016 //
REUTERS
Thalidomide maker hushed up drug`s side effects, German report says
14 May 2016 //
REUTERS
How will EU regulation keep pace with future therapies?
19 Jan 2016 //
MANUFACTURING CHEMIST
Exclusive: Drug That Caused `Elephant Man` Side Effect Makes Comeback After 2006 Disaster
25 Mar 2015 //
REUTERS
Biotechs’ Best Friend Celgene Sees Deal Strategy Put to Test
19 Mar 2015 //
BLOOMBERG BUSINESS
Mylan`s REMS Lawsuit against Celgene Gaining Traction
13 Jan 2015 //
BIOPHARMA DIVE